510(k) Report

510(k) · Cleared

Cleared

Joinsoon EON L Glucose Monitoring System and Joinsoon EON LS Glucose Monitoring System

K140325510(k) TraditionalCleared Oct 13, 2015610-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Joinsoon Medical Technology Co, Ltd. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Oct 13, 2015 as substantially equivalent to K072543 (Lifescan, Inc., 2007) after a 610-day review. Its family tree reaches back 1 generation to 2007.

Decided
Oct 13, 2015
Review
610 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K072543 (2007). No later device cites it as a predicate yet.

K072543 · Onetouch Select Blood Glucose Monitoring System · Lifescan, Inc. · 2007 · recalled200620082010201220142016
K072543 · Onetouch Select Blood Glucose Monitoring System · Lifescan, Inc. · 2007 · recalled0
  1. Root · 1 generation backK072543 Onetouch Select Blood Glucose Monitoring SystemLifescan, Inc. · 2007 · Recalled
  2. This deviceK140325 Joinsoon EON L Glucose Monitoring System and Joinsoon EON LS Glucose…Joinsoon Medical Technology Co, Ltd. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K072543Onetouch Select Blood Glucose Monitoring SystemLifescan, Inc.20071
0 (this device)K140325Joinsoon EON L Glucose Monitoring System and Joinsoon EON LS Glucose…Joinsoon Medical Technology Co, Ltd.2015—
FIG. 1 — Lineage of K140325, 2007–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072543Onetouch Select Blood Glucose Monitoring System
Summary page 5
…e: Glucose Oxidase Regulation: 862.1345 Product Code: CGA 4. Predicate Device Information: Lifescan OneTouch® Select Glucose Monitoring System K072543 1 5. Device Description: The Joinsoon® EON LS Glucose Mon…
Lifescan, Inc.20071

Also cleared against K072543: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 2 other devices also cite its predicate K072543.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Joinsoon® EON L Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips. The Joinsoon® EON L Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes in a home setting as an aid to monitor the effectiveness of diabetes control. The Joinsoon® EON L Glucose Monitoring System should not be…

Read the full statement (356 words)

The Joinsoon® EON L Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in

fresh capillary whole blood samples drawn from the fingertips.

The Joinsoon® EON L Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use)

by people with diabetes in a home setting as an aid to monitor the effectiveness of diabetes control. The Joinsoon® EON

L Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use.

The Joinsoon® EON L Glucose Monitoring System is intended to be used by a single person and should not be shared.

The Joinsoon® Single Strips are for use with the Joinsoon® EON L Glucose Meter to quantitatively measure glucose in

fresh capillary whole blood samples drawn from the fingertips.

The Joinsoon® Control Solution is for use with the Joinsoon® EON L Glucose Meter and Joinsoon® Single Strips as a

quality control check to verify that the meter and test strips are working together properly, and that the test is performing

correctly.

The Joinsoon® EON LS Glucose Monitoring System is intended to be used for the quantitative measurement of glucose

in fresh capillary whole blood samples drawn from the fingertips.

The Joinsoon® EON LS Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use)

by people with diabetes in a home setting as an aid to monitor the effectiveness of diabetes control. The Joinsoon® EON

LS Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use.

The Joinsoon® EON LS Glucose Monitoring System is intended to be used by a single person and should not be shared.

The Joinsoon® Snap Strips are for use with the Joinsoon® EON LS Glucose Meter to quantitatively measure glucose in

fresh capillary whole blood samples drawn from the fingertips.

The Joinsoon® Control Solution is for use with the Joinsoon® EON LS Glucose Meter and Joinsoon® Snap Strips as a

quality control check to verify that the meter and test strips are working together properly and that the test is performing

correctly.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Also cleared against K072543

2 other devices cite the same predicate.

  • K093745One Touch Verio Blood Glucose Monitoring SystemLifescan, Inc. · 2011
  • K082513Onetouch Vita Blood Glucose Monitoring SystemLifescan, Inc. · 2008

Recent decisions in NBW

The NBW category page

  • K261293EASYMAX Voice Blood Glucose Monitoring SystemEPS Bio Technology Corp. · 2026
  • K260687VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual…Vivachek Biotech (Hangzhou) Co., Ltd. · 2026
  • K260689CVS Advanced PLUS Blood Glucose Monitoring SystemI-Sens, Inc. · 2026
  • K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System…Ascensia Diabetes Care · 2026
  • K262116TRUE METRIX Self Monitoring Blood Glucose SystemTrividia Health, Inc. · 2026

https://510kreport.com/device/K140325 · printed Nov 6, 2026

Cite this page

510(k) Report. “K140325: Joinsoon EON L Glucose Monitoring System and Joinsoon EON LS Glucose Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140325

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026